Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An announcement from OncoSil Medical Ltd ( (AU:OSL) ) is now available.
OncoSil Medical Ltd announced an update regarding the issuance of securities under a Securities Purchase Plan (SPP), which was approved by shareholders during an Extraordinary General Meeting (EGM) held on July 8, 2025. This update includes an amendment to the number of shares and options, reflecting a 1 for 400 consolidation approved earlier on May 29, 2025, and the final SPP issue price announced on July 7, 2025. This move is part of the company’s strategic financial adjustments, potentially impacting its market positioning and shareholder value.
More about OncoSil Medical Ltd
OncoSil Medical Ltd operates in the medical industry, focusing on developing and commercializing innovative medical devices. The company’s primary product is a targeted radioactive isotope treatment for pancreatic and liver cancer, aiming to improve patient outcomes through advanced therapeutic solutions.
Average Trading Volume: 42,531
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$16.71M
Learn more about OSL stock on TipRanks’ Stock Analysis page.